#clinical trial

The Health Ministry will use the regular distribution channel for delivering the booster or third dose of the COVID-19 ...

A clinical trial of COVID-19 booster vaccinations has recorded no indications of severe adverse events following ...

ANANDA Scientific Inc., (a biotech pharma company) today announced approval by the U.S. Food and Drug Administration ...

Celltrion Group announced today results for its cocktail therapy candidates including neutralisation data against the ...

The University of Indonesia (UI) and Japan’s National Center for Global Health and Medicine (NCGM) signed a ...

Head of the National Agency of Drug and Food Control (BPOM), Penny Lukito, has said that the agency is aiming to start ...

LEO Pharma A/S, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration ...

President Joko Widodo (Jokowi) on Monday said that he wants Indonesia to stop importing medical devices, medicines, and ...

PT Biotis vaccine is still awaiting approval for the Phase I clinical trials from the National Agency of Drug and Food ...

The Indonesian government will push COVID-19 booster or third dose vaccinations starting from January 2022, the ...

The Merah Putih vaccine, developed by Indonesian scientists, could be utilized for both booster shots and regular ...

National Agency of Drug and Food Control (BPOM) Head Penny Kusumastuti Lukito encouraged all parties to synergize to ...

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

Protocols for the clinical trial of the Merah Putih vaccine, developed by Airlangga University (Unair), have entered ...

The National Population and Family Planning Agency (BKKBN) has modified the family planning service program in ...